We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acute Haemodynamic Impact of an IV Glucose-Injection

This study has been withdrawn prior to enrollment.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00426114
First Posted: January 24, 2007
Last Update Posted: April 10, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Ghent
  Purpose
Patients with peritoneal dialysis will be administered an IV glucose-injection to evaluate the haemodynamic impact of this injection. The patients will be matched with healthy volunteers.

Condition Intervention Phase
Peritoneal Dialysis Drug: Administration of an IV glucose-injection Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Acute Haemodynamic Impact of an IV Glucose-Injection

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Haemodynamic parameters
  • Glycemia

Estimated Enrollment: 20
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • > 18 years old
  • Stable clinical condition
  • Either peritoneal dialysis (at least one month) either matched healthy subject

Exclusion Criteria:

  • Heart Failure
  • Diabetes requiring insulin treatment
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00426114


Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Responsible Party: Wim Van Biesen, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00426114     History of Changes
Other Study ID Numbers: 2007/016
First Submitted: January 23, 2007
First Posted: January 24, 2007
Last Update Posted: April 10, 2009
Last Verified: April 2009